The emergence of advanced genome editing technologies has revolutionized research in life sciences, offering an unprecedented ...

The emergence of advanced genome editing technologies has revolutionized research in life sciences, offering an unprecedented way to uncover unknown ...

Learn more about whether Charles River Laboratories International, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...

Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through ...

Cambridge biotech Nuclera is on the march globally with its much vaunted benchtop eProtein Discovery system following two ...

At the recent ELRIG Drug Discovery conference, Technology Networks<i/> spoke with Dr. Kundan Sharma to learn more about how cell-free expression platforms are transforming membrane protein research.

Detailed price information for Microbix Biosystems Inc (MBXBF) from The Globe and Mail including charting and trades.

Acute sepsis profoundly changes how intravenous fluids behave within the body. Using a sheep model, researchers investigated ...

Peptides are everywhere; they’re unavoidable. Insulin is a peptide. So are GLP-1s—the Ozempics and Mounjaros of the world.

In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As ...

Acute kidney injury (AKI) remains one of the most dangerous complications in intensive care units (ICUs), affecting up to half of critically ill ...

Peptide therapeutics have progressed from insulin discovery to GLP-1 class molecules, revolutionizing diabetes treatment and ...